Nasvax
Biotechnology - , ,
Nasvax Employees
Nasvax Senior Management
Nasvax Details
NasVax develops improved vaccines and immunotherapeutic products. The company has four distinct product areas: i. oral anti-CD3 monoclonal antibody immunotherapeutic; ii. VaxiSome® technology, which is an adjuvant-delivery system for enhancing the immunogenicity of vaccines and immunotherapeutics; iii. group-common pneumococcal vaccine, which is a protein-based vaccine that could become the field's third-generation product; and iv. BBS1-based immunotherapeutics for Alzheimer's disease.
Website:
nasvax.com
Employees:
1 - 10
HQ:
["97289396577"]
Location:
, ,
Revenue: